title: Differential angiogenic and proliferative activity of surgical and burn wound fluids.
abstract: BACKGROUND
  Invasive surgical wounds exhibit the rapid production of a robustly proangiogenic environment. To compare the immediate angiogenic environment of wounds of different types, the angiogenic activity of fluid derived from burn injuries and wounds confined to the dermis was examined and compared with that of deeper surgical wounds.
  
  
  METHODS
  The angiogenic activity of surgical wound fluid (SWF) (n = 7), skin graft wound fluid (SGF) (n = 3), and burn wound fluid (BWF) (n = 4) was assessed by measuring endothelial cell (EC) proliferative activity, EC chemotactic activity, and angiogenic activity in the rat corneal assay. The fibroblast growth factor-2 (FGF-2) level of each wound fluid was determined by enzyme-linked immunosorbent assay.
  
  
  RESULTS
  SWF exhibited significant EC proliferative activity, SGF exhibited intermediate activity, and BWF displayed no EC proliferative activity. Seventy-one percent of SWF samples, 33% of SGF, and 0% of BWF contained significant EC chemotactic activity. Each wound fluid sample that demonstrated significant chemotactic activity also evoked a positive corneal angiogenic response. SWF contained 914 +/- 170 pg/mL of FGF-2, whereas SGF and BWF contained just 164 +/- 54 pg/mL and 37 +/- 7 pg/mL of FGF-2, respectively.
  
  
  CONCLUSIONS
  The results suggest that injuries confined to the dermis, whether thermal or excisional, elicit a less robust initial angiogenic stimulus than deep surgical wounds.
authors.affiliation: Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California, USA.
authors.forename: Nicholas N
authors.initials: NN
authors.lastname: Nissen
authors.forename: Richard L
authors.initials: RL
authors.lastname: Gamelli
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Polverini
authors.forename: Luisa A
authors.initials: LA
authors.lastname: DiPietro
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001681:Biological Assay; D002056:Burns / Q000503:physiopathology*; D002455:Cell Division; D002478:Cells, Cultured; D003315:Cornea / Q000098:blood supply; D004728:Endothelium, Corneal / Q000254:growth & development / Q000473:pathology; D005122:Exudates and Transudates / Q000737:chemistry / Q000502:physiology*; D016222:Fibroblast Growth Factor 2 / Q000032:analysis; D005347:Fibroblasts / Q000473:pathology / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D018919:Neovascularization, Physiologic / Q000502:physiology*; D051381:Rats; D016038:Skin Transplantation / Q000502:physiology; D014945:Wound Healing / Q000502:physiology*; D014950:Wounds, Penetrating / Q000503:physiopathology*
chemical_list: D016222:Fibroblast Growth Factor 2